{
    "title": "Quantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS",
    "abstract": "The discovery of small molecules with therapeutic potential is a long-standing challenge in chemistry and biology. Researchers have increasingly leveraged novel computational techniques to streamline the drug development process to increase hit rates and reduce the costs associated with bringing a drug to market. To this end, we introduce a quantum-classical generative model that seamlessly integrates the computational power of quantum algorithms trained on a 16-qubit IBM quantum computer with the established reliability of classical methods for designing small molecules. Our hybrid generative model was applied to designing new KRAS inhibitors, a crucial target in cancer therapy. We synthesized 15 promising molecules during our investigation and subjected them to experimental testing to assess their ability to engage with the target. Notably, among these candidates, two molecules, ISM061-018-2 and ISM061-22, each featuring unique scaffolds, stood out by demonstrating effective engageme",
    "link": "https://arxiv.org/abs/2402.08210",
    "context": "Title: Quantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS\nAbstract: The discovery of small molecules with therapeutic potential is a long-standing challenge in chemistry and biology. Researchers have increasingly leveraged novel computational techniques to streamline the drug development process to increase hit rates and reduce the costs associated with bringing a drug to market. To this end, we introduce a quantum-classical generative model that seamlessly integrates the computational power of quantum algorithms trained on a 16-qubit IBM quantum computer with the established reliability of classical methods for designing small molecules. Our hybrid generative model was applied to designing new KRAS inhibitors, a crucial target in cancer therapy. We synthesized 15 promising molecules during our investigation and subjected them to experimental testing to assess their ability to engage with the target. Notably, among these candidates, two molecules, ISM061-018-2 and ISM061-22, each featuring unique scaffolds, stood out by demonstrating effective engageme",
    "path": "papers/24/02/2402.08210.json",
    "total_tokens": 935,
    "translated_title": "量子计算增强的算法揭示了KRAS的新抑制剂",
    "translated_abstract": "发现具有治疗潜力的小分子一直是化学和生物学中的长期挑战。研究人员越来越多地利用新颖的计算技术来简化药物开发流程，提高药物的发现率，并降低将药物推向市场的成本。为此，我们引入了一个将16比特IBM量子计算机上的量子算法的计算能力与设计小分子的传统可靠的经典方法无缝集成的量子-经典生成模型。我们的混合生成模型被应用于设计新的KRAS抑制剂，这是癌症治疗中的一个重要靶点。在我们的研究中，我们合成了15种有希望的分子，并对它们进行了实验测试，以评估它们与靶点的结合能力。值得注意的是，在候选分子中，两种具有独特骨架的分子，ISM061-018-2和ISM061-22，通过展示有效的与靶点的结合能力而脱颖而出。",
    "tldr": "我们通过将量子算法的计算能力与经典方法的可靠性相结合，提出了一个量子-经典生成模型，用于设计癌症治疗中的关键分子靶点KRAS的新的抑制剂。在研究中合成了15种有希望的分子，并通过实验测试验证了其中两种分子的有效结合能力。",
    "en_tdlr": "We propose a quantum-classical generative model that integrates the computational power of quantum algorithms and the reliability of classical methods for designing new inhibitors for KRAS, a crucial molecular target in cancer therapy. Through experimental testing, we synthesized and identified two promising molecules with effective engagement capabilities."
}